ANTIMICROBIAL RESISTANCE CONTROL
Posted on: March 26, 2018, by : sumedho

WORKSHOP – 10:

Wednesday, 18 July 2018, RS Penyakit Infeksi Prof. Dr. Sulianti Saroso

Objectives:

  1. To increase the awareness of amr problem
  2. To increase the rational use if antibiotics
  3. To increase the use of microbiology examination and its clinical implementation

 

Target audiences:

Clinicians, PPRA RS Team

Time

Programme

07.30 – 08.00

Registration

08.00 – 08.15

AMR Situation and Control in South East Asia Region of WHO
Tjandra Yoga Aditama (Senior Advisor, WHO SEARO)

08.15 – 08.30

Keynote Speech and Opening Remarks
Bambang Wibowo (Directorate General of Health Services – INA)

08.30 –08.45

Introduction and Pre Test
Dewi Anggraini (INA)

08.45 – 09.15

Global Problem of Antimicrobial Resistance (AMR)
Hari Parathon (Chairman of AMR Control Comittee, MoH – INA)
Outline:
AMR situation in the world
Strategies to prevent the end the antibiotic era

09.15 – 09.45

Antimicrobial Resistance Control Program (PPRA) in 1st Edition of National Standard of Hospital Accreditation (SNARS  1st Edition)
Djoni Darmadjaja (SNARS  – INA)
Outline:
1. Why is AMR control program included in SNARS?
2. What are the parameter of assessment?

09.45 –10.15

Basic Principles of Rational Antibiotic Use
Taralan Tambunan (INA)
Outline: AMU for prophylaxis and therapies

10.15 –10.30

Coffee Break

10.30 –11.15

Appropriate Microbiology Specimens Handling for Accurate Results
Ardiana Kusumaningrum (INA)
Outline: pre analytic of microbiology examination

11.15 – 12.00

Expert Rules of Antimicrobial Susceptibility Test Results
Dewi Anggraini (INA)
Outline: expert rules of AST based in CLSI and EUCAST

12.00 – 12.45

Pharmacokinetic and Pharmacodynamic of Antibiotics in Respiratory Tract Infection
Rianto Setiabudi (INA)
Outline: PK/PD of antibiotic for respiratory tract (oral and parenteral)

12.45 – 13.30

Lunch

13.30 – 14.15

Clinical Implementation of Microbiological Test Results
Anis Karuniawati (INA)
Outline:
1. interpretation of microb results
2. action taken base on result

14.15 – 15.00

Development of Antibiotic Use Guideline
Erlina Burhan (INA)

15.00 –15.45

Case Discussion 1:
Respiratory Tract Infection (Community-Acquired Pneumonia)
Linda Masniari (INA)

15.45 –16.00

Coffee Break

16.00 –16.45

Case Discussion 2:
Respiratory Tract Infection (Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia)
Pompini Agustina (INA)

16.45 –17.00

Post-test and closing
Dewi Anggraini (INA)